OLD BROWSER ! We have noticed that you are using an old Internet browser. For a better browsing experience, we recommend that you use a different browser or upgrade to a newer version of your browser.
Oxathiapiprolin Approved
Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
| Legislation | Reg. (EU) 2017/239 | ||
|---|---|---|---|
| Date of approval | 03/03/2017 | Expiration of approval | 03/03/2027 |
| RMS | IE
|
Risk Assessment | EFSA |
| Category | FU | Review Report |
Approval 2016
List of studies 2016 |
| Remarks | Admissible application according to Article 9 of Regulation (EC) No 1107/2009. Date of admissibility: 16/01/2014 | ||
Authorisation at national level
| Authorised in | In progress for |
|---|---|
| AT, BE, CZ, DE, FR, IE, IT, LT, NL, PT, UK | EE, ES, FI, HU, SI, SK |
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
| Legislation | Annexes |
|---|---|
|
Classification Reg. 1272/2008
| No classification |
Toxicological information
| Reference values | Source | Remark | |
|---|---|---|---|
| ADI | 0.14 | Reg. (EU) 2017/239 | |
| ARfD | Not applicable | Reg. (EU) 2017/239 | |
| AOEL | 0.04 | Reg. (EU) 2017/239 | |
| Other | |||
- Legend
-
- RMS:Rapporteur Member State
- Co-RMS:Co-Rapporteur Member State
- ADI:Acceptable daily intake
- ARfD:Acute reference dose
- AOEL:Acceptable operator exposure level